Aurobindo Pharma Limited - Company & Market Research Reports

Home /
Companies /
Aurobindo Pharma Limited

Founded in 1986, Aurobindo manufactures generic pharmaceutical drugs. The company has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues. It exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations.

REFINE BY

KEYWORD

CATEGORIES

Infectious Diseases Drugs 78
Cardiovascular Drugs 71
Antibiotics 55
Generic Drugs 47
Central Nervous System Drugs 43
Respiratory Drugs 42
Immune Disorders Drugs 41
Gastrointestinal Drugs 41
Pharmaceutical Intermediates 40
Musculoskeletal Disorders Drugs 37
Urological Disorders Drugs 33
Oncology Drugs 31
Analgesics 31
Pharmaceuticals 27
Sexual and Reproductive Health Drugs 27
Animal Pharmaceuticals 26
Endocrine and Metabolic Disorders Drugs 23
Bronchitis Drugs 23
Mental Disorders Drugs 21
Lung Cancer Drugs 17
HIV/AIDS Drugs 17
Pharmaceutical Manufacturing 17
Infusions and Injectables 16
Over the Counter (OTC) Drugs 16
Anxiety Drugs 15
Vitamins and Dietary Supplements 13
Allergy and Immunology 11
Optical Disorders Drugs 10
Cough and Cold Drugs 10
Hematological Drugs 10
Dermatological Drugs 10
Drug Discovery 9
Breast Cancer Drugs 9
Liver and Kidney Disorders Drugs 9
Acne Drugs 9
Women's Health 8
Biopharmaceuticals 8
Gastroenterology 8
Alzheimer's Disease Drugs 8
Asthma Drugs 8
Immunosuppressive Drugs 8
Ovarian Cancer Drugs 7
Pancreatic Cancer Drugs 7
Drugs by Therapeutic Area 6
Diabetes Drugs 6
Prostate Cancer Drugs 6
Kidney Cancer Drugs 6
Thyroid Cancer Drugs 6
Schizophrenia Drugs 6
Pulmonary Medicine 5
Urology and Nephrology 5
Colon Cancer Drugs 5
Optical 5
Addiction Disorders Drugs 4
Healthcare Services 4
Leukemia Drugs 4
Brain Cancer Drugs 4
Bladder Cancer Drugs 4
Infectious Disease Testing 4
Enzymes 4
Mental Health 4
Skin Cancer Drugs 4
Company Reports 3
Therapeutic Area 3
Neurology 3
Cervical Cancer Drugs 3
Clinical Trials 3
Anesthetic Drugs 3
Biosimilars and Biosuperiors 3
Oncology 3
Psoriasis Drugs 3
Biotechnology 2
Liver Cancer Drugs 2
Fertility Services 2
In Vitro Diagnostics 2
Transdermal and Transmucosal Drug Delivery 2
Diagnostics 2
Drug Delivery 2
Sports Medicine and Physiotherapy 2
Surgical Devices 2
Vaccines 2
Uterine Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Lymphoma Drugs 1
Genomics 1
Point-of-Care Diagnostics 1
Healthcare 1
Diabetes Devices 1
Inhalers and Nebulisers 1
Medical Devices 1
Respiratory Devices 1
Needles and Syringes 1
Dermatology 1
Surgical Procedures 1
Hematology 1
Nuclear Medicine and Radiopharmacology 1
Laboratory Equipment 1
Intensive Care and Emergency Medicine 1
Cardiology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

705 Results (Page 16 of 36)
- Relevance
  Sort by

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
2271 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Brain Health Supplements Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
August 2024
91 Pages
Global

From

€3500EUR$4,255USD£3,182GBP

Alzheimers Disease Therapeutics Market 2025-2029

 Report
May 2025
225 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Radiopharmaceutical Theranostics Market Report and Forecast 2023-2031

 Report
July 2023
140 Pages
Global

From

€4361EUR$4,949USD£3,831GBP

Branded Generics - Global Strategic Business Report

 Report
December 2025
354 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Barrett's Esophagus Market - Global Strategic Business Report

 Report
December 2025
274 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Expectorant Drugs Market - Global Strategic Business Report

 Report
December 2025
464 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Generic Drugs Market - Global Forecast 2025-2032

 Report
October 2025
189 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Liposome Development and Liposome Manufacturing Services Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Formulation, Scale of Operation, Type of End User, and Key Geographical Regions

 Report
March 2025
230 Pages
Global

From

€4229EUR$4,799USD£3,714GBP

Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
August 2023
215 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Antibiotics - Global Strategic Business Report

 Report
December 2025
266 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029

 Report
February 2024
122 Pages
Global

From

€1976EUR$2,243USD£1,736GBP

€2635EUR$2,990USD£2,314GBP

Lurasidone Hydrochloride Tablet Market - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Lenvatinib Drugs Market - Global Forecast 2025-2030

 Report
August 2025
181 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Generic Drugs Market 2025-2029

 Report
March 2025
221 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Diabetic Kidney Diseases Market - Global Strategic Business Report

 Report
December 2025
372 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Diuretic Drugs - Global Strategic Business Report

 Report
December 2025
372 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Lenalidomide Market by Type and by Application, by End-User, and By Region

 Report
March 2024
200 Pages
Global

From

€3657EUR$4,150USD£3,212GBP

Altretamine Market - Global Forecast 2025-2032

 Report
October 2025
199 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

Olaparib API Market - Global Forecast 2025-2030

 Report
August 2025
182 Pages
Global

From

€3124EUR$3,545USD£2,744GBP

€3471EUR$3,939USD£3,049GBP

705 Results (Page 16 of 36)
- 1
- 14
- 15
- 16
- 17
- 18

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.